This document's authors say the development of plant-derived vaccines is straightforward, and that their production could "easily and economically be established in developing countries".

Drawing on consultations with international experts, they examine the elements needed to realise the advantages of plant-derived vaccines for developing countries, emphasising the need for public–private collaboration.

An important requirement, they say, would be to effectively keep drug-producing transgenic plants out of the food supply. How the plant material is processed, packaged and stored is also important.

The document provides an overview of these and other issues, and will be useful to policy analysts, entrepreneurs and decision-makers exploring the potential of plant-derived vaccines.

Go to key document